Tag: biomedical
-
ALS Therapy Start-Up Gains $5.1M in Seed Funds
A start-up enterprise is developing a treatment for amyotrophic lateral sclerosis or ALS, spun off from university research labs and an ALS advocacy group.
-
Trial Begins for Advanced Covid-19 Disease Anti-Viral
A late-stage clinical trial is underway testing an oral anti-viral drug to treat moderate to severe cases of Covid-19 infections.
-
Challenge Seeks A.I. Antibody Enhancement Platform
A challenge competition is seeking computational biology teams to propose a new technology with artificial intelligence for enhancing antibody therapies.
-
Infographic – Cancer Drugs Main Pharma Money Source
Our infographic this weekend displays revenue sources overall for drug makers, and the leader by a wide margin is cancer drugs.
-
Pharma Company Licenses Protein Delivery Hydrogel
A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue.
-
FDA Issues Guidance for Non-Opioid Acute Pain Relief
The Food and Drug Administration released for comment review processes for new non-opioid drugs to relieve acute or temporary pain episodes.
-
University Lab Licenses Printed Kidney Tissue Process
A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure.
-
Synthetic SARS-CoV-2 Particle Designed for Drug R&D
Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers.
-
Alzheimer’s Vaccine Shown to Produce Immune Response
In tests with lab animals, an experimental vaccine is shown to generate antibodies responding to toxic brain proteins associated with Alzheimer’s disease.
-
Start-Ups Partner on Quantum Computing and Longevity
Two companies formed in the last two years are applying quantum computing and artificial intelligence to discover new treatments for improving human longevity.